| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/12/2004 | EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 05/12/2004 | EP0804577B1 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 05/12/2004 | EP0792156B1 Medicaments for the prevention or treatment of vascular hemorrhaging |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | EP0607425B1 Epstein-barr virus peptides and antibodies against these peptides |
| 05/12/2004 | CN1496412A Method for estimating danger of diabetes typ B developed in the human species of Chinese bloodline and composition |
| 05/12/2004 | CN1496410A Methods |
| 05/12/2004 | CN1496404A Materials and methods relating to protein aggregation in neurodegenerative disease |
| 05/12/2004 | CN1496403A Plant-derived molecules and genetic sequences encoding same and uses therefor |
| 05/12/2004 | CN1496370A Isolated GUM operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1496368A Immunopotentiators |
| 05/12/2004 | CN1496268A Vesicular stromatitis virus (VSV) |
| 05/12/2004 | CN1495429A Method for detecting dangerous of decayed tooth |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495255A Method for obtaining non-occluded baculovirus |
| 05/12/2004 | CN1495200A New fusion protein as carrier |
| 05/12/2004 | CN1495198A Analogs of glucagon-like peptide-1 |
| 05/12/2004 | CN1495197A G-CSF analogs composition and its preparation method |
| 05/12/2004 | CN1495196A Purification of human myocardium troponin I and preparation method of its monoclonal anti-body |
| 05/12/2004 | CN1495195A Transgenic animal for expressing androgen receptor compound relatea protein |
| 05/12/2004 | CN1495191A HNF-1 alpha gene variant with new mononucleotide polymorphism and its coded protein variant |
| 05/12/2004 | CN1495190A Polynuleotide fragment of white-spot disease baculovirus and method for detecting virus by using it |
| 05/12/2004 | CN1494922A Purification method of dermatonecrotoxin and anatoxin produced by Bordetella |
| 05/12/2004 | CN1494919A Embonate medicine composition containing bombesin-like product |
| 05/12/2004 | CN1494900A Slow releasing composition and its preparing method |
| 05/12/2004 | CN1149293C Male tissue-perferred regulatory region and method of using same |
| 05/12/2004 | CN1149289C Promoter from ashbya gossypii |
| 05/12/2004 | CN1149288C Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 05/12/2004 | CN1149287C Recombinant mersacidin and method for production |
| 05/12/2004 | CN1149286C Ligand polypeptides for the G-protein-coupled recetpor protein, their production and use |
| 05/12/2004 | CN1149285C Expression of ocean fish antifreeze peptide in food grade organism and its application in food products |
| 05/11/2004 | US6734344 Coniothyrium minitans β-(1,3) exoglucanase gene cbeg 1 |
| 05/11/2004 | US6734340 Monocotyledon plant cells and plants which synthesise modified starch |
| 05/11/2004 | US6734336 Useful in identifying compounds for treating alzheimer's disease |
| 05/11/2004 | US6734293 Novel extracts, proteins, and complexes that improve the polymerization activity of nucleic acid polymerases |
| 05/11/2004 | US6734289 Gastrokines and derived peptides including inhibitors |
| 05/11/2004 | US6734288 Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage |
| 05/11/2004 | US6734285 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, inflammation, diabetic retinopathy, rheumatoid arthritis and psoriasis |
| 05/11/2004 | US6734284 Exhibits high affinity for the gfr alpha 3- ret receptor complex and unique subregions in its amino acid sequence |
| 05/11/2004 | US6734283 Detection, modulation, activation of conjugation involving the protein nedd8 (neural precursor cell-expressed developmentally down regulated); |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734173 HSP DNA vaccines |
| 05/11/2004 | US6734172 Surface receptor antigen vaccines |
| 05/11/2004 | US6734169 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 05/11/2004 | US6734168 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/11/2004 | US6734164 Addition of cysteine delays the temporal decrease in the effective concentration of the protein. the process is suitable for use in the production of heterologous proteins in microorganisms. |
| 05/11/2004 | US6734163 Administering composition of tissure factor pathway inhibitor, homolog or active fragment with anti-proliferative activity; treating angiogenesis related diseases; cancer; arthritis; macular degeneration; diabetic retinopathy |
| 05/11/2004 | US6734160 Nucleotide sequences coding polypeptide for use in the treatment of diabetes |
| 05/11/2004 | US6734019 Used in plant breeding |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6734002 Nucleotide sequences coding for the chrS protein |
| 05/11/2004 | US6733997 Isolated nucleic acids encoding a secretory signal for expression and secretion of heterologous recombinant proteins |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733993 Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
| 05/11/2004 | US6733992 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 05/11/2004 | US6733991 For indentifying receptor-independent activators of pheromone response pathway; devised in yeast saccharomyces cerevisiae; activator of g-protein signaling (ags) |
| 05/11/2004 | US6733990 Useful for the treatment of immune, hematologic, fibrotic, hepatic, and respiratory disorders such as asthma using g-protein coupled receptors (gpcr) |
| 05/11/2004 | US6733989 Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), the preparation and use thereof |
| 05/11/2004 | US6733988 For suppression of cross-link formation |
| 05/11/2004 | US6733981 Antibodies to interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 05/11/2004 | US6733973 Diagnostic reagents for human cytomegalovirus and methods of use |
| 05/11/2004 | US6733971 Method for identifying an agent that affects a hedgehog signaling pathway |
| 05/11/2004 | US6733970 Screening system for zinc finger polypeptides for a desired binding ability |
| 05/11/2004 | US6733760 Recombinant toxin A/toxin B vaccine against Clostridium difficile |
| 05/11/2004 | US6733758 Fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 05/11/2004 | US6733757 Adeno-associated virus capsid polypeptide for use as gene transfer tool in cell tranduction |
| 05/11/2004 | US6733755 Ligand for vascular endothelial growth factor receptor |
| 05/11/2004 | US6733753 Composition and method for treating inflammatory diseases |
| 05/11/2004 | US6733130 Method for refracting and dispensing electro-active spectacles |
| 05/11/2004 | CA2074188C Vector with multiple tat activation response elements affecting gene expression |
| 05/06/2004 | WO2004038377A2 Method for diagnosing renal diseases or predispositions |
| 05/06/2004 | WO2004038375A2 Water soluble toxin produced by pfiesteria species |
| 05/06/2004 | WO2004038373A2 Apoptotic response regulation through interaction of tripartite motif protein 32 with pias |
| 05/06/2004 | WO2004038372A2 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004038371A2 Ccr8 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004038034A1 Novel fructosyl peptide oxidase and utilization thereof |
| 05/06/2004 | WO2004038033A1 Defructosylation method |
| 05/06/2004 | WO2004038028A2 Hepatitis x virus antigen |
| 05/06/2004 | WO2004038025A2 Genes and proteins for the biosynthesis of the glycopeptide antibiotic a40926 |
| 05/06/2004 | WO2004038021A1 Gpr54 knock-out mammals and screening methods using them |
| 05/06/2004 | WO2004038020A1 Target genes for the diagnosis and treatment of cancer |
| 05/06/2004 | WO2004038018A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 05/06/2004 | WO2004038016A1 Method of degrading plastic and process for producing useful substance using the same |
| 05/06/2004 | WO2004038015A1 Crystal structure of cytochrome p450 3a4 and its use |
| 05/06/2004 | WO2004038008A2 Modulation of cellular proliferation |
| 05/06/2004 | WO2004038003A2 Human polypeptides encoded by polynucleotides and methods of their use |
| 05/06/2004 | WO2004037998A2 Natural promoters for gene expression in c1 metabolizing bacteria |
| 05/06/2004 | WO2004037997A2 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof |
| 05/06/2004 | WO2004037995A2 Methods for treating viral infection using il-28 and il-29 |
| 05/06/2004 | WO2004037993A2 Methods of producing a library and methods of selecting polynucleotides of interest |
| 05/06/2004 | WO2004037992A2 Mapk7 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004037991A2 Prkcb1 as modifier of branching morphogenesis and methods of use |
| 05/06/2004 | WO2004037987A2 Secreted proteins |
| 05/06/2004 | WO2004037986A2 Map2k6 as modifier of branching morphogenensis and methods of use |
| 05/06/2004 | WO2004037985A2 Modulation of g protein coupled receptor activity |
| 05/06/2004 | WO2004037984A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2004 | WO2004037976A2 NONSENSE-MEDIATED mRNA DECAY |
| 05/06/2004 | WO2004037972A2 Endogenous retrovirus up-regulated in prostate cancer |